Chronic myelomonocytic leukemia with nucleophosmin (NPM1) mutation-Reference-Cited by-同舟云学术

Chronic myelomonocytic leukemia with nucleophosmin (NPM1) mutation

Published:2015-04-21 Issue:1 Volume:96 Page:65-71
ISSN:0902-4441
Container-title:European Journal of Haematology
language:en
Short-container-title:Eur J Haematol

Author:

Peng Jie¹²,Zuo Zhuang¹,Fu Bin¹²,Oki Yasuhiro³,Tang Guilin¹,Goswami Maitrayee¹,Priyanka Priyanka¹,Muzzafar Tariq¹,Medeiros L. Jeffrey¹,Luthra Rajyalakshmi¹,Wang Sa A.¹

Affiliation:

1. Department of Hematopathology; The University of Texas MD Anderson Cancer Center; Houston TX USA

2. Department of Hematology; Central South University Xiangya Hospital; Changsha China

3. Department of Lymphoma/Myeloma; The University of Texas MD Anderson Cancer Center; Houston TX USA

Publisher

Wiley

Subject

Hematology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/ejh.12549/fullpdf

Reference27 articles.

1. NPM1 gene type A mutation in Bulgarian adults with acute myeloid leukemia: a single-institution study;Balatzenko;Turk J Haematol,2014

2. Cytoplasmic nucleophosmin in acute myelogenous leukemia with a normal karyotype;Falini;N Engl J Med,2005

3. Nucleophosmin mutations in acute myeloid leukemia: a tale of protein unfolding and mislocalization;Federici;Protein Sci,2013

4. Prevalence and prognostic impact of NPM1 mutations in 1485 adult patients with acute myeloid leukemia (AML);Thiede;Blood,2006

5. Influence of new molecular prognostic markers in patients with karyotypically normal acute myeloid leukemia: recent advances;Mrozek;Curr Opin Hematol,2007

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evolution from an antecedent chronic myeloid malignancy does not impact survival outcomes in NPM1‐mutated AML;European Journal of Haematology;2024-08-08

2. NPM1‐mutated myeloid neoplasms are a unique entity not defined by bone marrow blast percentage;Cancer;2024-06-19

3. Infrequent Presentations of Chronic NPM1-Mutated Myeloid Neoplasms: Clinicopathological Features of Eight Cases from a Single Institution and Review of the Literature;Cancers;2024-02-07

4. Myelodysplastic Syndromes/Myeloproliferative Overlap Neoplasms and Differential Diagnosis in the WHO and ICC 2022 Era: A Focused Review;Cancers;2023-06-13

5. The Times, They Are A-Changing: The Impact of Next-Generation Sequencing on Diagnosis, Classification, and Prognostication of Myeloid Malignancies With Focus on Myelodysplastic Syndrome, AML, and Germline Predisposition;American Society of Clinical Oncology Educational Book;2023-06